GGrantIndex
← Leaderboards

Julian Abrams

Columbia University Health Sciences

Google Scholar ↗PubMed ↗ORCID ↗
$10,470,386
Attributed
$13,039,137
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.1M · FY2008–25
$5M$3.8M$2.5M$1.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,626,518 · 11

By mechanism

R01$8,985,253 · 3
U54$3,228,215 · 3
P30$894,796 · 2
K07$776,754 · 1
T32$579,128 · 1
R03$162,372 · 1

Top collaborators

Most similar at Columbia University Health Sciences

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms”

Research focus

Malignant NeoplasmsNeoplasmsBarrett EsophagusEsophageal AdenocarcinomaDysplasiaIncidenceSamplingMicrobiomeRisk FactorsFutureCohortPublic HealthCessation Of LifeTranslatingAreaGut MicrobiomeCellsEnrollmentLesionProductionHigh RiskBile AcidsEsophagusBacteria

Grant awards (43)

The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia$583,975
R01 · FY2025 · CA · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$466,166
R01 · FY2025 · CA · contact PI
Multidisciplinary Training in Gastrointestinal Cancers$385,984
T32 · FY2025 · CA · contact PI
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia$245,000
R01 · FY2025 · CA · contact PI
The Clinical Biospecimen and Research Core$212,898
P30 · FY2025 · DK · contact PI
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia$787,527
R01 · FY2024 · CA · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$468,404
R01 · FY2024 · CA · contact PI
The Clinical Biospecimen and Research Core$216,188
P30 · FY2024 · DK · contact PI
Multidisciplinary Training in Gastrointestinal Cancers$193,144
T32 · FY2024 · CA · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$99,686
R01 · FY2024 · CA · contact PI
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia$812,396
R01 · FY2023 · CA · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$523,932
R01 · FY2023 · CA · contact PI
The Oral Microbiome for the Detection of Barretts Esophagus$396,636
R01 · FY2023 · CA · contact PI
The Clinical Biospecimen and Research Core$227,541
P30 · FY2023 · DK · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$70,807
R01 · FY2023 · CA · contact PI
The Role of Secondary Bile Acids in Gastro-Esophageal Neoplasia$845,100
R01 · FY2022 · CA · contact PI
The Oral Microbiome for the Detection of Barretts Esophagus$545,129
R01 · FY2022 · CA · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$510,755
R01 · FY2022 · CA · contact PI
The Role of the Microenvironment in Barrett's Esophagus$441,975
U54 · FY2022 · CA · contact PI
The Clinical Biospecimen and Research Core$238,169
P30 · FY2022 · DK · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$219,406
R01 · FY2022 · CA · contact PI
The Role of the Microenvironment in Barrett's Esophagus$1,145,406
U54 · FY2021 · CA · contact PI
The Role of the Microbiome and Notch Signaling in Esophageal Adenocarcinoma$525,287
R01 · FY2021 · CA · contact PI
Project 3: Application of the Microbiome and Microenvironment to Novel Non Endoscopic Screening and Surveillance in Barrett's Esophagus$474,801
U54 · FY2021 · CA · contact PI
The Oral Microbiome for the Detection of Barretts Esophagus$469,156
R01 · FY2021 · CA · contact PI
Study of the Oral Microbiome to Address Racial Disparities in Esophageal Cancer$233,500
R01 · FY2021 · CA · contact PI
The Role of the Metaplastic Microenvironment in Barrett's Esophagus$223,884
R01 · FY2021 · CA · contact PI
Administrative Core$59,298
U54 · FY2021 · CA · contact PI
The Oral Microbiome for the Detection of Barretts Esophagus$462,380
R01 · FY2020 · CA · contact PI
Project 3: Application of the Microbiome and Microenvironment to Novel Non Endoscopic Screening and Surveillance in Barrett's Esophagus$263,770
U54 · FY2020 · CA · contact PI
The Oral Microbiome for the Detection of Barretts Esophagus$496,127
R01 · FY2019 · CA · contact PI
Project 3: Application of the Microbiome and Microenvironment to Novel Non Endoscopic Screening and Surveillance in Barrett's Esophagus$275,411
U54 · FY2019 · CA · contact PI
Project 3: Application of the Microbiome and Microenvironment to Novel Non Endoscopic Screening and Surveillance in Barrett's Esophagus$239,231
U54 · FY2018 · CA · contact PI
Project 3: Application of the Microbiome and Microenvironment to Novel Non Endoscopic Screening and Surveillance in Barrett's Esophagus$13,322
U54 · FY2018 · CA · contact PI
Project 3: Application of the Microbiome and Microenvironment to Novel Non Endoscopic Screening and Surveillance in Barrett's Esophagus$315,001
U54 · FY2017 · CA · contact PI
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts Esophagus$81,186
R03 · FY2016 · CA · contact PI
Randomized Placebo-Controlled Trial of a Gastrin Receptor Antagonist in Barretts Esophagus$81,186
R03 · FY2015 · CA · contact PI
Risk factors for site-specific metastasis in esophageal cancer$135,351
K07 · FY2012 · CA · contact PI
Risk factors for site-specific metastasis in esophageal cancer$135,351
K07 · FY2011 · CA · contact PI
Risk factors for site-specific metastasis in esophageal cancer$135,351
K07 · FY2010 · CA · contact PI
Risk factors for site-specific metastasis in esophageal cancer$135,351
K07 · FY2009 · CA · contact PI
Risk factors for site-specific metastasis in esophageal cancer$99,999
K07 · FY2009 · CA · contact PI
Risk factors for site-specific metastasis in esophageal cancer$135,351
K07 · FY2008 · CA · contact PI